Assessment of berberine as a multi-target antimicrobial: A multi-omics study for drug discovery and repositioning

OMICS A Journal of Integrative Biology

Volumn 18, Issue 1, 2014, Pages 42-53

  Karaosmanoglu, Kubra ^a   Sayar, Nihat Alpagu ^a   Kurnaz, Isil Aksan ^b   Akbulut, Berna Sariyar ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE;

AMINO ACID METABOLISM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DNA REPLICATION; DRUG DEVELOPMENT; DRUG REPOSITIONING; DRUG SCREENING; ENERGY CONVERSION; ENERGY YIELD; ESCHERICHIA COLI; GENE REPRESSION; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; MEMBRANE PERMEABILITY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS;

ANTI-BACTERIAL AGENTS; BERBERINE; BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; DATA MINING; DNA REPAIR; DNA REPLICATION; DRUG RESISTANCE, BACTERIAL; ENERGY METABOLISM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, MDR; GENOME, BACTERIAL; TRANSCRIPTOME;

EID: 84893147959     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0100     Document Type: Article

References (78)

1. Albrecht R, Zeth K, Soding J, Lupas A, and Linke D. (2006). Expression, crystallization and preliminary X-ray crystallographic studies of the outer membrane protein OmpW from Escherichia coli. Acta Cryst 62, 415-418
2. Berg HC. (2003). The rotary motor of bacterial flagella. Annu Rev Biochem 72, 19-54
3. Bernhardt TG, and de Boer PA. (2005). SlmA, a nucleoidassociated, FtsZ-binding protein required for blocking septal ring assembly over chromosomes in E. coli. Mol Cell 18, 555-564
4. Bhadra K, and Kumar GS. (2011). Therapeutic potential on nucleic acid-binding isoquinoline alkaloids: Binding aspects and implications for drug design. Med Res Rev 6, 821-862
5. Bishop RE, Leskiw BK, Hodges RS, Kay CM, and Weiner JH. (1998). The entericidin locus of Escherichia coli and its implications for programmed bacterial cell death. J Mol Biol 280, 583-596
6. Boberek JM, Stach J, and Good L. (2010). Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS ONE 5, e13745
7. Boran ADW, and Iyengar R. (2010). Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel 13, 297-309
8. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem 12, 248-254
9. Bustanji Y, Taha MO, Yousef AM, and Al-Bakri AG. (2006). Berberine potently inhibits protein tyrosine phosphatase 1B: Investigation by docking simulation and experimental validation. J Enzyme Inhib Med Chem 21, 163-171
10. Chatuphonprasert W, Sangkawat T, Nemoto N, and Jarukamjorn K. (2011). Suppression of beta-naphthoflavone induced CYP1A expression and lipid-peroxidation by berberine. Fitoterapia 82, 889-895
11. Chen C, Zhang Y, and Huang C. (2010). Berberine inhibits PTP1B activity and mimics insulin action. Biochem Biophys Res Commun 397, 543-547
12. Chen XW, Di YM, Zhang J, Zhou ZW, Li CG, and Zhou SF. (2012). Interaction of herbal compounds with biological targets: A case study with berberine. Sci World J 2012, e708292
13. Cho H, McManus HR, Dove SL, and Bernhardt TG. (2011). Nucleoid occlusion factor SlmA is a DNA-Activated FtsZ polymerization antagonist. Proc Natl Acad Sci USA 108, 3773-3778
14. Chung JG, Wu LT, Chu CB, et al. (1999). Effects of berberine on arylamine N-Acetyltransferase activity in human bladder tumour cells. Food Chem Toxicol 37, 319-326
15. Chung JG, Chen GW, Hung CF, et al. (2000). Effects of berberine on arylamine N-Acetyltransferase activity and 2-Aminofluorene-DNA adduct formation in human leukemia cells. Am J Chin Med 28, 227-238
16. Csermely P, Agoston V, and Pongor S. (2005). The efficiency of multi-Target drugs: The network approach might help drug design. TRENDS Pharmacol Sci 26, 178-182
17. Dewick PM. (2009). Medicinal Natural Products: A Biosynthetic Approach, 3rd ed. Wiley & Sons, West Sussex, England
18. Domadia PN, Bhunia A, Sivaraman J, Swarup S, and Dasgupta D. (2008). Berberine targets assembly of Escherichia coli cell division protein FtsZ. Biochemistry 47, 3225-3234
19. Domitrovic R, Jakovac H, and Blagojevic G. (2011). Hepatoprotective activity of berberine is mediated by inhibition of TNFa, COX-2, and iNOS expression in CCl4-intoxicated mice. Toxicology 280, 33-43
20. dos Santos KV, Diniz CG, Veloso Lde C, et al. (2010). Proteomic analysis of Escherichia coli with experimentally induced resistance topiperacillin/ tazobactam. Res Microbiol 161, 268-275
21. Draper GC, Mclennan N, Begg K, Masters M, and Donachie WD. (1998). Only the N-Terminal domain of FtsK functions in cell division. J Bacteriol 180, 4621-4627
22. Farewell A, Diez AA, DiRusso CC, and Nyström T. (1996). Role of the Escherichia coli FadR regulator in stasis survival and growth phase-dependent expression of the uspA, fad, and fab genes. J Bacteriol 178, 6443-6450
23. Fu H, Liu LG, Peng JP, Leng WC, Yang J, and Jin Q. (2010). Transcriptional profile of Shigella flexneri response to an alkaloid: Berberine. FEMS Microbiol Lett 303, 169-175
24. Giel JL, Rodionov D, Liu M, Blattner FR, and Kiley PJ. (2006). IscR-dependent gene expression links iron-sulphur cluster assembly to the control of O2-regulated genes in Escherichia coli. Mol Microbiol 60, 1058-1075
25. Grycova L, Dostal J, and Marek R. (2007). Quaternary protoberberine alkaloids. Phytochemistry 68, 150-175
26. Hambraeus G, von Wachenfeldt C, and Hederstedt L. (2003). Genome-wide survey of mRNA half-lives in Bacillus subtilis identifies extremely stable mRNAs. Mol Genet Genomics 269, 706-714
27. Harley CB, and Reynolds RP. (1987). Analysis of E. coli promoter sequences. Nucleic Acids Res 15, 2343-2361
28. Helmann JD, and Chamberlin MJ. (1988). Structure and function of bacterial sigma factors. Ann Rev Biochem 57, 839-872
29. Hu, Z, Saez C, and Lutkenhaus J. (2003). Recruitment of MinC, an inhibitor of Z-ring formation, to the membrane in Escherichia coli: Role of MinD and MinE. J Bacteriol 185, 196-203
30. Kawano M, Aravind L, and Storz G. (2007). An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol Microbiol 64, 738-754
31. Kenyon CJ, and Walker GC. (1980). DNA-damaging agents stimulate gene expression at specific loci in Escherichia coli. Proc Natl Acad Sci USA 77, 2819-2823
32. Kern WV, Steinke P, Schumacher A, Schuster S, von Baum H, and Bohnert JA. (2006). Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57, 339-343
33. Keseler IM, Collado-Vides J, Gama-Castro S, et al. (2005). Eco-Cyc: A comprehensive database resource for Escherichia coli. Nucleic Acids Res 33, 334-337
34. Kim S, and Chung JH. (2008). Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts. Phytomedicine 15, 749-753
35. Kisker C, Schindelin H, Baas D, Reetey JU, Meckenstock RU, and Kroneck PMH. (1999). A structural comparison of molybdenum cofactor-containing enzymes. FEMS Microbiol Rev 22, 503-521
36. Klose J, and Kobalz U. (1985). Two-dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome. Electrophoresis 16, 1034-1059
37. Korea CG, Badouraly R, Prevost MC, Ghigo JM, and Beloin C. (2010). Escherichia coli K-12 possesses multiple cryptic but functional chaperone-usher fimbriae with distinct surface specificities. Environment Microbiol 12, 1957-1977
38. Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
39. Lane MC, Simms AN, and Mobley HL. (2007). Complex interplay between type 1 fimbrial expression and flagellummediated motility of uropathogenic Escherichia coli. J Bacteriol 189, 5523-5533
40. Lau SY, and Zgurskaya HI. (2005). Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-TolC. J Bacteriol 187, 7815-7825
41. Lee LJ, Barrett JA, and Poole RK. (2005). Genome-wide transcriptional response of chemostat-cultured E. coli to zinc. J Bacteriol 187, 1124-1134
42. Li Z, Garner AL, Gloeckner C, Janda KD, and Carlow CK. (2011). Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy. PLOS Negl Tropic Dis 5, e1411
43. Lin JG, Chung JG, Wu LT, Chen GW, Chang HL, and Wang TF. (1999). Effects of berberine on arylamine N-Acetyltransferase activity in human colon tumor cells. Am. J Chin Med. 27, 265-275
44. Lin WC, and Lin JY. (2011). Berberine down-regulates the Th1/ Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive manner. Intl Immunopharmacol 11, 1984-1990
45. Liu YF, Yan JJ, Lei HY, Teng CH, Wang MC, Tseng CC, and Wuf JJ. (2012). Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infection Immunity 80, 1815-1822
46. Lomba MR, Vasconcelos AT, Pacheco AB, and de Almeida DF. (1997). Identification of yebG as a DNA damage-inducible Escherichia coli gene. FEMS Microbiol Lett 156, 119-122
47. Lu JJ, Pan W, Hu YJ, and Wang YT. (2012). Multi-Target drugs: The trend of drug research and development. PLOS One 7, e40262
48. Lukey MJ, Parkin A, Roessler MM, et al. (2010). How Escherichia coli is equipped to oxidize hydrogen under different redox conditions. J Biol Chem 285, 3928-3938
49. Mazzini S, Bellucci MC, and Mondelli R. (2003). Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2). Bioorg Med Chem 11, 505-514
50. Moussatova A, Kandt C, O'Mara ML, and Tieleman DP. (2008). ATP-binding cassette transporters in Escherichia coli. Biochim Biophys Acta. 1778, 1757-1771
51. Nachin L, Nannmark U, and Nyström T. (2005). Differential roles of the universal stress proteins of Escherichia coli in oxidative stress resistance, adhesion, and motility. J Bacteriol 187, 6265-6272
52. Nikaido H, and Zgurskaya HI. (2001). AcrAB and related multidrug efflux pumps of Escherichia coli. J Mol Microbiol Biotechnol 3, 215-218
53. Ogawa T, and Okazaki T. (1994). Cell cycle-dependent transcription from the gid and mioC promoters of Escherichia coli. J Bacteriol 176, 1609-1615
54. Ozbalci C, Unsal C, Kazan D, and Sariyar Akbulut B. (2010). Proteomic response of Escherichia coli to the alkaloid extract of Papaver polychaetum. Ann Microbiol 60, 709-717
55. Paulsen IT, Chen J, Nelson KE, and Saier MH, Jr. (2001). Comparative genomics of microbial drug efflux systems. J Mol Microbiol Biotechnol 3, 145-150
56. Parrilli E, Giuliani M, and Tutino ML. (2008). General secretory pathway from marine Antarctic Pseudoalteromonas haloplanktis TAC125. Mar Genomics 1, 123-128
57. Piddock LJV. (2006). Multidrug-resistance efflux pumps-not just for resistance. Nature Rev Microbiol 4, 629-636
58. Quan S, Koldewey P, Tapley T, et al. (2011). Genetic selection designed to stabilize proteins uncovers a-chaperone called Spy. Nat Struct Mol Biol 18, 262-269
59. Radakovits R, Jinkerson RE, Darzins A, and Posewitz MC. (2010). Genetic engineering of algae for enhanced biofuel production. Eukaryotic Cell, Am Soc Microbiol 9, 486-501
60. Radhouani H, Pinto L, Poeta P, and Igrejas G. (2012). After genomics, what proteomic tools could help us understand the antimicrobial resistance of Escherichia coli? J Proteomics 75, 2773-2789
61. Reusch RN. (2012). Insights into the structure and assembly of Escherichia coli outer membrane protein A. FEBS J 279, 894-909
62. Schoenbart B, and Ellen S. (2007). Traditional Chinese medicine for the digestive system. http://health.howstuffworks.com/ wellness/natural-medicine/ Chinese/traditional-chinesemedicine-for-The-digestive-system1.htm. Last accessed on 5/11/13
63. Shen B, and Lutkenhaus J. (2009). The conserved C-Terminal tail of FtsZ is required for the septal localization and division inhibitory activity of MinC(C)/MinD. Mol Microbiol 72, 410-424
64. Shevchenko A, Thomas H, Havlis J, Olsen JV, and Mann M. (2007). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1, 2856-2860
65. Singh A, Duggal S, Kaur N, and Singh J. (2010). Berberine: Alkaloid with wide spectrum of pharmacological activities. J Nat Products 3, 64-75
66. Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, and Mobley HLT. (2011). Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: Contribution of Ygi and Yad fimbriae. Infect Immun 79, 4753-4763
67. Stafford GP, Ogi T, and Hughes C. (2005). Binding and transcriptional activation of non-flagellar genes by the Escherichia coli flagellar master regulator FlhD2C2. Microbiology 151, 1779-1788
68. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, and Lewis K. (2000). Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5. *-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 97, 1433-1437
69. Sun D, Abraham SN, and Beachey EH. (1988). Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother 32, 1274-1277
70. Thanassi DG, and Hultgren SJ. (2000). Multiple pathways allow protein secretion across the bacterial outer membrane. Curr Opin Cell Biol 12, 420-430
71. Wang L, and Lutkenhaus J. (1998). FtsK is an essential cell division protein that is localized to the septum and induced as part of the SOS response. Mol Microbiol 29, 731-740
72. Wang DY, Yeh CC, Lee JH, Hung CF, and Chung JG. (2002). Berberine inhibited arylamine N-Acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells. Neurochem Res 27, 883-889
73. Wang D, Yu L, Xiang H, Fan J, He L, Guo N, Feng H, and Deng X. (2008). Transcriptional profile of Staphylococcus aureus treated with berberine. FEMS Microbiol Lett 279, 217-225
74. Wang Y, Kheir MM, Chai Y, Hu J, Xing D, Lei F, and Lijun D. (2011). Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box. PLOS One 6, e23495
75. White-Ziegler CA, Villapakkam A, Ronaszeki K, and Young S. (2000). H-NS controls pap and daa fimbrial transcription in Escherichia coli in response to multiple environmental cues. J Bacteriol 182, 6391-6400
76. Wu LT, Tsou MF, Ho CC, Chuang JY, Kuo HM, and Chung JG. (2005). Berberine inhibits arylamine N-Acetyltransferase activity and gene expression in Salmonella typhi. Curr Microbiol 51, 255-261
77. Zhang J, Zuo G, Bai Q, Wang Y, Yang R, Qiu J. (2009). Transcriptional profiling of Yersinia pestis treated with berberine. Planta Med 75, 396-398
78. Zhang Y, Wang X, Sha S, et al. (2012). Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model. Fitoterapia 83, 1014-1022